查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
下一代测序信息学市场 - 2018-2028 年全球行业规模、份额、趋势、竞争、机会和预测，按产品和服务、应用程序、最终用户、地区细分
市场调查报告书
商品编码
1342707

下一代测序信息学市场 - 2018-2028 年全球行业规模、份额、趋势、竞争、机会和预测，按产品和服务、应用程序、最终用户、地区细分

Next Generation Sequencing Informatics Market-Global Industry Size, Share, Trends, Competition, Opportunity, & Forecast, 2018-2028 Segmented By Products & Services, Application, End User, Region
出版日期: | 出版商: TechSci Research | 英文 114 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

由于癌症患病率不断上升以及下一代测序 (NGS) 临床应用的增加，预计全球下一代测序 (NGS) 信息学市场在 2024-2028 年预测期内将出现令人印象深刻的增长。根据全球癌症观察站的数据，2020 年，全球报告了约 19,292,789 例新癌症病例。乳腺癌、肺癌、结直肠癌、前列腺癌和胃癌是 2020 年报告的最常见的癌症病例。此外，DNA 测序样本数量的增加，通过使用下一代测序降低了 DNA 测序的成本（ NGS）信息学、各种政府倡议、不断增加的临床应用、下一代测序（NGS）取代微阵列技术是促进市场增长的其他因素。

慢性病患病率上升

在全球范围内，癌症是导致死亡的主要原因。根据世界卫生组织的数据，过去五年，全球报告了约 50,550,287 例癌症病例。这是由于存在物理致癌物（如紫外线和电离辐射）、化学致癌物（如石棉、烟草烟雾、酒精、黄曲霉毒素（一种食品污染物）和砷（一种饮用水污染物））以及生物致癌物（如寄生虫感染和不健康物质）而导致的。生活方式的选择。当今医疗保健的一个主要问题是癌症。对新型癌症疗法的需求预计将推动全球下一代测序（NGS）信息学市场的扩张。

同样，艾滋病毒、人乳头瘤病毒和结核病等致命且需要潜在治疗的新型病毒性疾病的日益流行，预计将进一步推动全球下一代测序（NGS）信息学市场的增长。截至 2021 年，全球约有 3840 万人感染艾滋病毒。

下一代测序 (NGS) 临床研究的增加

临床研究是由两个组成部分组成的医学研究：观察性研究和临床试验。临床研究活动通过下一代测序（NGS）识别病毒基因组序列，从而保护人类健康。下一代测序（NGS）技术在研究病毒基因组突变及其对人类健康的影响方面发挥着至关重要的作用。根据 2020 年《临床组学》(Clinical OMICS) 上发表的一篇研究文章，大约 84,000 个冠状病毒病毒基因组序列已上传到全球共享所有流感数据倡议 (GISAID)。此外，全基因组和转录组测序、宏基因组学等应用程序用于不同微生物样本的表征，这反过来有望推动全球下一代测序（NGS）信息学市场的增长。

DNA 微阵列技术的替代

随着最近的进步和测序成本的大幅下降，下一代测序（下一代测序（NGS））的普及度直线上升。随着成本变得越来越低，方法变得更简单和更广泛，研究人员正在选择下一代测序（NGS）而不是微阵列来进行更多的基因组应用。此外，下一代测序 (NGS) 有可能提供更高分辨率和更全面的基因组视图。

这清楚地表明，全球正在开展大量研发活动，利用下一代测序（NGS）测序来治疗人类健康，从而支持全球下一代测序（NGS）信息学市场的增长。

可用的定制

根据给定的市场数据，TechSci Research 可根据公司的具体需求提供定制服务。该报告可以使用以下自定义选项：

公司信息

  • 其他市场参与者（最多五个）的详细分析和概况分析。

目录

第 1 章：产品概述

  • 市场定义
  • 市场范围
    • 涵盖的市场
    • 考虑学习的年份
    • 主要市场细分

第 2 章：研究方法

  • 研究目的
  • 基线方法
  • 主要行业合作伙伴
  • 主要协会和二手资料来源
  • 预测方法
  • 数据三角测量和验证
  • 假设和限制

第 3 章：执行摘要

  • 市场概况
  • 主要市场细分概述
  • 主要市场参与者概述
  • 重点地区/国家概况
  • 市场驱动因素、挑战、趋势概述

第 4 章：客户之声

第 5 章：全球下一代测序 (NGS) 信息学市场展望

  • 市场规模及预测
    • 按价值
  • 市场份额及预测
    • 按产品和服务（存储和计算工具、商业数据分析、数据解释和报告工具、下一代测序 (NGS) 信息学服务、实验室信息管理系统 (LIMS)）
    • 按应用（药物发现、基因筛查、疾病诊断等）
    • 按最终用户（医院和诊断中心、製药和生物技术公司、学术和研究机构）
    • 按地区（北美、欧洲、亚太地区、南美、中东和非洲）
    • 按公司划分 (2022)
  • 市场地图
    • 按产品和服务
    • 按应用
    • 按最终用户
    • 按地区

第 6 章：北美下一代测序 (NGS) 信息学市场展望

  • 市场规模及预测
    • 按价值
  • 市场份额及预测
    • 按产品和服务
    • 按应用
    • 按最终用户
    • 按国家/地区
  • 北美：国家分析
    • 美国
    • 加拿大
    • 墨西哥

第 7 章：欧洲下一代测序 (NGS) 信息学市场展望

  • 市场规模及预测
    • 按价值
  • 市场份额及预测
    • 按产品和服务
    • 按应用
    • 按最终用户
    • 按国家/地区
  • 欧洲：国家分析
    • 德国
    • 法国
    • 英国
    • 意大利
    • 西班牙

第 8 章：亚太地区下一代测序 (NGS) 信息学市场展望

  • 市场规模及预测
    • 按价值
  • 市场份额及预测
    • 按产品和服务
    • 按应用
    • 按最终用户
    • 按国家/地区
  • 亚太地区：国家分析
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳大利亚

第 9 章：南美洲下一代测序 (NGS) 信息学市场展望

  • 市场规模及预测
    • 按价值
  • 市场份额及预测
    • 按产品和服务
    • 按应用
    • 按最终用户
    • 按国家/地区
  • 南美洲：国家分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第 10 章：中东和非洲下一代测序 (NGS) 信息学市场展望

  • 市场规模及预测
    • 按价值
  • 市场份额及预测
    • 按产品和服务
    • 按应用
    • 按最终用户
    • 按国家/地区
  • MEA：国家分析
    • 阿联酋下一代测序 (NGS) 信息学
    • 沙特阿拉伯下一代测序 (NGS) 信息学
    • 南非下一代测序 (NGS) 信息学
    • 土耳其下一代测序 (NGS) 信息学
    • 埃及下一代测序 (NGS) 信息学

第 11 章：市场动态

  • 司机
    • 慢性病患病率上升
    • 下一代测序 (NGS) 临床研究的增加
    • DNA 微阵列技术的替代

第 12 章：挑战

    • 缺乏训练有素的临床人员来进行下一代测序 (NGS) 实验
    • 全球范围内下一代测序 (NGS) 的报销率较低

第 13 章：市场趋势与发展

第14章：竞争格局

  • 商业概览
  • 产品供应
  • 最近的发展
  • 财务（据报导）
  • 主要人员
    • Abbott Laboratories, Inc.
    • F. Hoffmann-La Roche Ltd.
    • PerkinElmer, Inc.
    • SOPHiA GENETICS SA
    • Precigen, Inc.
    • QIAGEN NV
    • Illumina, Inc.
    • Agilent Technologies, Inc.
    • Eagle Genomics Limited
    • BGI Genomics Co., Ltd.

第 15 章：战略建议

简介目录
Product Code: 15017

Global Next Generation Sequencing (NGS) Informatics Market is anticipated to observe an impressive growth during the forecast period, 2024-2028 owing to growing prevalence of cancer and increase in clinical applications for Next Generation Sequencing (NGS). According to Global Cancer Observatory, in 2020, around 19,292,789 new cancer cases were reported worldwide. Breast Cancer, Lung Cancer, Colorectum Cancer, Prostate Cancer and Stomach Cancer were the most prevalent types of cancer cases reported in 2020. Additionally, increase in number of samples for DNA sequencing, reduced cost of DNA sequencing with the use of Next Generation Sequencing (NGS) informatics, various government initiatives, rising clinical applications, substitution of Microarray technology by Next Generation Sequencing (NGS) are other factors contributing to market growth.

The growing prevalence of new viral diseases has significantly increased the demand for Next Generation Sequencing (NGS) Informatics market. Additionally, growing research & development activities being initiated by various governments and pharmaceutical & biotechnology companies across the globe is further expected to create lucrative opportunities for the growth of Next Generation Sequencing (NGS) Informatics market in the coming years. In 2021, the research & development expenditure in the pharmaceutical industry across the globe was around USD238 billion.

Rise in Prevalence of Chronic Diseases

Globally, the cancer is the leading cause of death. According to World Health Organization, around 50,550,287 cases of cancer have been reported worldwide in the last five years. This is brought due to the presence of physical carcinogens like ultraviolet and ionising radiation, chemical carcinogens like asbestos, tobacco smoke, alcohol, aflatoxin (a food contaminant), and arsenic (a drinking water contaminant), and biological carcinogens like parasite infections and unhealthy lifestyle choices. A major issue in healthcare nowadays is cancer. The demand for novel cancer therapies is anticipated to fuel the expansion of the global Next Generation Sequencing (NGS) Informatics market.

Similarly, the increasing prevalence of new viral diseases such as HIV, Human Papillomavirus and Tuberculosis which are deadly and require a potential treatment is further expected to drive the growth of global Next Generation Sequencing (NGS) Informatics Market. As of 2021, globally around 38.4 million people were living with HIV.

Increase in Clinical Research for Next Generation Sequencing (NGS)

Clinical research is medical research constituting two components: observational studies, clinical trials. The clinical research activities result in taking care of the human health by identifying the viral genome sequence through Next Generation Sequencing (NGS). The Next Generation Sequencing (NGS) technique plays a vital role in studying the mutations in the viral genome and their impact on human health as well. According to a research article published in Clinical OMICS, 2020, approximately 84,000 viral genomic sequences of the coronavirus have been uploaded to the Global Initiative to Share All Influenza Data (GISAID). Additionally, the application like whole genome and transcriptome sequencing, metagenomics, etc. is used for the characterization of different microbial samples which in turn is expected to fuel the growth of Global Next Generation Sequencing (NGS) Informatics Market.

Substitution of DNA Microarray Technology

With recent advancements and a radical decline in sequencing costs, the popularity of next generation sequencing (Next Generation Sequencing (NGS)) has skyrocketed. As costs become less prohibitive and methods become simpler and more widespread, researchers are choosing Next Generation Sequencing (NGS) over microarrays for more of their genomic applications. Additionally, Next Generation Sequencing (NGS) has the potential to offer even higher resolution and a more comprehensive view of the genome.

This clearly indicates that a lot of R&D is being done across the globe for utilizing Next Generation Sequencing (NGS) sequencing for the treatment of human health, thereby supporting the growth of global Next Generation Sequencing (NGS) Informatics Market.

Market Segmentation

Global Next Generation Sequencing (NGS) Informatics Market can be segmented based on products & services, application, end user, region and competitional landscape. Based on products & services, the market can be categorized into storage and computing tools, commercial data analysis, data interpretation, and reporting tools, Next Generation Sequencing (NGS), laboratory information management systems (LIMS). Based on application, the market can be fragmented into drug discovery, genetic screening, disease diagnosis, and others. Based on end user, the market can be divided into hospitals and diagnostic centers, pharmaceutical and biotechnology companies, academic and research institutions.

Company Profiles

Abbott Laboratories, Inc., F. Hoffmann-La Roche Ltd., PerkinElmer, Inc., SOPHiA GENETICS SA, Precigen, Inc., QIAGEN N.V., Illumina, Inc., Agilent Technologies, Inc., Eagle Genomics Limited, BGI Genomics Co., Ltd. are some of the key players operating in the Global Next Generation Sequencing (NGS) Informatics Market.

Report Scope

In this report, Global Next Generation Sequencing (NGS) Informatics Market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Next Generation Sequencing (NGS) Informatics Market, By Products & Services:

  • Storage and Computing Tools
  • Commercial Data Analysis
  • Data Interpretation, and Reporting Tools
  • Next Generation Sequencing (NGS)
  • Laboratory Information Management Systems (LIMS)

Next Generation Sequencing (NGS) Informatics Market, By Application:

  • Drug Discovery
  • Genetic Screening
  • Disease Diagnosis
  • Others

Next Generation Sequencing (NGS) Informatics Market, By End User:

  • Hospitals and Diagnostic Centers
  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institutions

Next Generation Sequencing (NGS) Informatics Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • South Africa
    • Turkey
    • Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Next Generation Sequencing (NGS) Informatics Market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Next Generation Sequencing (NGS) Informatics Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Products & Services (Storage and Computing Tools, Commercial Data Analysis, Data Interpretation, and Reporting Tools, Next Generation Sequencing (NGS) Informatics Services, Laboratory Information Management Systems (LIMS))
    • 5.2.2. By Application (Drug Discovery, Genetic Screening, Disease Diagnosis, and Others)
    • 5.2.3. By End User (Hospitals and Diagnostic Centers, Pharmaceutical and Biotechnology Companies, Academic and Research Institutions)
    • 5.2.4. By Region (North America, Europe, Asia Pacific, South America, Middle East, and Africa)
    • 5.2.5. By Company (2022)
  • 5.3. Market Map
    • 5.3.1. By Products & Services
    • 5.3.2. By Application
    • 5.3.3. By End User
    • 5.3.4. By Region

6. North America Next Generation Sequencing (NGS) Informatics Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Products & Services
    • 6.2.2. By Application
    • 6.2.3. By End User
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Next Generation Sequencing (NGS) Informatics Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Products & Services
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By End User
    • 6.3.2. Canada Next Generation Sequencing (NGS) Informatics Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Products & Services
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By End User
    • 6.3.3. Mexico Next Generation Sequencing (NGS) Informatics Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Products & Services
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By End User

7. Europe Next Generation Sequencing (NGS) Informatics Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Products & Services
    • 7.2.2. By Application
    • 7.2.3. By End User
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Next Generation Sequencing (NGS) Informatics Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Products & Services
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By End User
        • 7.3.1.2.4. By Country
    • 7.3.2. France Next Generation Sequencing (NGS) Informatics Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Products & Services
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By End User
    • 7.3.3. United Kingdom Next Generation Sequencing (NGS) Informatics Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Products & Services
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By End User
    • 7.3.4. Italy Next Generation Sequencing (NGS) Informatics Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Products & Services
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By End User
    • 7.3.5. Spain Next Generation Sequencing (NGS) Informatics Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Products & Services
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By End User

8. Asia-Pacific Next Generation Sequencing (NGS) Informatics Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Products & Services
    • 8.2.2. By Application
    • 8.2.3. By End User
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Next Generation Sequencing (NGS) Informatics Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Products & Services
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By End User
    • 8.3.2. Japan Next Generation Sequencing (NGS) Informatics Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Products & Services
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By End User
    • 8.3.3. India Next Generation Sequencing (NGS) Informatics Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Products & Services
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By End User
    • 8.3.4. South Korea Next Generation Sequencing (NGS) Informatics Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Products & Services
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By End User
    • 8.3.5. Australia Next Generation Sequencing (NGS) Informatics Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Products & Services
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By End User

9. South America Next Generation Sequencing (NGS) Informatics Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Products & Services
    • 9.2.2. By Application
    • 9.2.3. By End User
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Next Generation Sequencing (NGS) Informatics Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Products & Services
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By End User
    • 9.3.2. Argentina Next Generation Sequencing (NGS) Informatics Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Products & Services
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By End User
    • 9.3.3. Colombia Next Generation Sequencing (NGS) Informatics Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Products & Services
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By End User

10. Middle East and Africa Next Generation Sequencing (NGS) Informatics Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Products & Services
    • 10.2.2. By Application
    • 10.2.3. By End User
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. UAE Next Generation Sequencing (NGS) Informatics Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Products & Services
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By End User
    • 10.3.2. Saudi Arabia Next Generation Sequencing (NGS) Informatics Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Products & Services
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By End User
    • 10.3.3. South Africa Next Generation Sequencing (NGS) Informatics Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Products & Services
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By End User
    • 10.3.4. Turkey Next Generation Sequencing (NGS) Informatics Market Outlook
      • 10.3.4.1. Market Size & Forecast
        • 10.3.4.1.1. By Value
      • 10.3.4.2. Market Share & Forecast
        • 10.3.4.2.1. By Products & Services
        • 10.3.4.2.2. By Application
    • 10.3.5. Egypt Next Generation Sequencing (NGS) Informatics Market Outlook
      • 10.3.5.1. Market Size & Forecast
        • 10.3.5.1.1. By Value
      • 10.3.5.2. Market Share & Forecast
        • 10.3.5.2.1. By Products & Services
        • 10.3.5.2.2. By Application
        • 10.3.5.2.3. By End User

11. Market Dynamics

  • 11.1. Drivers
    • 11.1.1. Rise in Prevalence of Chronic Diseases
    • 11.1.2. Increase in clinical research for Next Generation Sequencing (NGS)
    • 11.1.3. Substitution of DNA Microarray Technology

12. Challenges

    • 12.1.1. Lack of trained clinical personnel for conducting Next Generation Sequencing (NGS) experiments
    • 12.1.2. Poor reimbursement rates for Next Generation Sequencing (NGS) across the globe

13. Market Trends & Developments

14. Competitive Landscape

  • 14.1. Business Overview
  • 14.2. Product Offerings
  • 14.3. Recent Developments
  • 14.4. Financials (As Reported)
  • 14.5. Key Personnel
    • 14.5.1. Abbott Laboratories, Inc.
    • 14.5.2. F. Hoffmann-La Roche Ltd.
    • 14.5.3. PerkinElmer, Inc.
    • 14.5.4. SOPHiA GENETICS SA
    • 14.5.5. Precigen, Inc.
    • 14.5.6. QIAGEN N.V.
    • 14.5.7. Illumina, Inc.
    • 14.5.8. Agilent Technologies, Inc.
    • 14.5.9. Eagle Genomics Limited
    • 14.5.10. BGI Genomics Co., Ltd.

15. Strategic Recommendations